Filing Details
- Accession Number:
- 0001225208-24-009728
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-07 16:45:08
- Reporting Period:
- 2024-11-05
- Accepted Time:
- 2024-11-07 16:45:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1533022 | F Michael Mahoney | 300 Boston Scientific Way Marlborough MA 01752-1234 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-05 | 56,211 | $17.26 | 1,628,307 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-05 | 55,676 | $16.31 | 1,683,983 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-05 | 2,596 | $85.17 | 1,681,387 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-05 | 160,182 | $84.74 | 1,521,205 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-05 | 56,211 | $0.00 | 56,211 | $17.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-05 | 55,676 | $0.00 | 55,676 | $16.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 168,635 | 2026-02-22 | No | 4 | M | Direct | |
| 0 | 2025-02-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 209,278 | Indirect | By Trust |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $85.14 to $85.20, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $84.145 to $85.12, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
Billionaire Hedge Funds
